Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BEAT

BEAT - BioTelemetry Inc Stock Price, Fair Value and News

$1.36-0.11 (-7.48%)
Market Closed

Price Targets

BEAT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BEAT Price Action

Last 7 days

-2.9%

Last 30 days

3.0%

Last 90 days

-40.9%

Trailing 12 Months

-32.7%

BEAT RSI Chart

BEAT Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BEAT Valuation

Market Cap

55.9M

Price/Earnings (Trailing)

-2.66

EV/EBITDA

-2.45

Price/Free Cashflow

-3.83

MarketCap/EBT

-2.66

BEAT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

BEAT Fundamentals

BEAT Earnings

Earnings (TTM)

-21.0M

Earnings Growth (Yr)

-8.05%

Earnings Growth (Qtr)

-0.89%

BEAT Profitability

Return on Equity

-807.34%

Return on Assets

-359.66%

Free Cashflow Yield

-26.11%

BEAT Investor Care

Shares Dilution (1Y)

21.83%

Diluted EPS (TTM)

-0.62

About BioTelemetry Inc

BEAT
HeartBeam, Inc., a medical technology company, primarily focuses on developing and commercializing ambulatory electrocardiogram solutions that enable the detection and monitoring of cardiac disease inside and outside a healthcare facility setting. The company develops three-dimensional vector images of cardiac electrical activity. It is developing HeartBeam AIMIGo, a credit card-sized cloud-based diagnostic software systems to address heart attack detection. The company was incorporated in 2015 and is based in Santa Clara, California.
 CEO
 WEBSITEheartbeam.com
 SECTORHealthcare
 INDUSTRYHealth Information Services
 EMPLOYEES10

BioTelemetry Inc Frequently Asked Questions

BEAT is the stock ticker symbol of BioTelemetry Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Fri Mar 13 2026, market cap of BioTelemetry Inc is 55.88 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

In the past 10 years, BioTelemetry Inc has provided -0.197 (multiply by 100 for percentage) rate of return.